Plain-English translation of NCT06179602 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is collecting medical information and imaging data from patients who receive thermal ablation—a minimally invasive heat treatment—for liver cancer or tumors that have spread to the liver. By gathering this real-world data from many patients across Europe, researchers aim to develop artificial intelligence tools that will help doctors better select patients for treatment, plan procedures more precisely, and predict which patients might have cancer return after therapy.
Liver cancer can be difficult to treat, and doctors need better ways to decide which patients will benefit most from heat-based ablation, how to plan each treatment precisely, and how to know if the treatment worked. This study aims to use artificial intelligence and data from many patients to make thermal ablation more effective, personalized, and available as a first-line treatment option worldwide.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive your heat-based liver ablation treatment as normally planned by your medical team. The study involves sharing your medical records, imaging scans, and treatment outcomes with the research team so they can build a large database to train artificial intelligence tools. Your participation helps researchers develop better ways to personalize and optimize this treatment for future patients, with no change to your own medical care.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Netherlands